Embraya is an IVF medication tracker and cycle planning app for iOS and Android that allows users to manage multiple treatment cycles and medical history.
Product velocity
Maintenance
Daily rank 🇺🇸
—
Health & Fitness
Sentiment
5.0
21 reviews
Nemesis
Fragmented field
The App DNA
What makes this app unique?
Users hire Embraya to offload the high mental burden of managing complex, time-sensitive IVF medication schedules and appointments, replacing manual spreadsheets with a structured digital record.
For Individuals undergoing IVF treatment who need a centralized, organized way to manage complex medication schedules, appointments, and medical history.
What does it look like?
Key features
Tracks multiple IVF treatment cycles, allowing users to switch between retrievals and transfers while maintaining historical data.
Provides reminders, inventory tracking, and injection side rotation for IVF medications.
Logs embryo grades, PGT-A/PGT-M results, transfer dates, and storage status.
How much does it cost?
The app has transitioned from a free tool to a paywall-gated model, which has triggered negative sentiment among early users.
Velocity
Maintenance developmentnew contentUX improvementsShow more...
Embraya: IVF Tracker shows a maintenance-level release cadence based on the provided history. The latest version is a significant update that adds comprehensive tracking features for medical data, expenses, and personal wellness. Development is currently focused on expanding core utility rather than frequent iterative updates. Future momentum will depend on whether this feature-rich release is followed by regular maintenance or further expansion.
Who built it?
Embraya
2 apps tracked · Health & Fitness
User Sentiment
What do users think recently?
Recent user voice shows a frustrated sentiment. Users appreciate the comprehensive tracking features effectively reduce the mental load for users managing their fertility journey.
How are ratings & reviews evolving?
What users say, by theme
- The comprehensive tracking features effectively reduce the mental load for users managing their fertility journey
- Medication notification timing shifts post-update prevent users from adhering to strict fertility treatment schedules
3 of 3 recent reviews analyzed · limited sample
Read the full review analysisUnlock 1 more frustration theme, each backed by review evidence.
Access the full report for freeCompetition
Competitive landscape for Embraya: IVF Tracker
How's the Health & Fitness market?
Embraya operates in the Health & Fitness category, currently holding a 5-star rating across 21 reviews on iOS. The lack of Android reviews suggests a nascent presence on the platform, signaling that the app is currently in an early-stage acquisition phase.
Read the market outlookThe rivals identified
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for Embraya: IVF Tracker
Where is it heading?
The fertility tracking market is increasingly sensitive to reliability, as users rely on these tools for time-critical medical protocols. Embraya's recent technical regressions and monetization shifts suggest a pivot toward revenue that currently outpaces its product stability, so the PM must stabilize the core notification loop to prevent churn.
- Notification latency in the latest version creates adherence risks, which erodes the core utility of the app for IVF patients.
- The introduction of a paywall has triggered immediate user frustration, signaling potential friction in the current acquisition funnel.
The SWOT
- Multi-cycle historical tracking creates a longitudinal medical record
- Phase-based educational content reduces upfront cognitive load
- Integration with fertility clinic portals could automate data entry
Next best moves
Rebuild notification service because late alerts cause medication adherence failures → restore user trust
+ 1 more prioritized moveThe counter-intuitive read
The move to a paywall is premature…
Read the full takeSince the last report: The app transitioned to a freemium pricing model, which has introduced user friction and shifted the competitive outlook to mixed.
Bottom line
Embraya provides unique value through its multi-cycle tracking mechanism, but technical instability in medication reminders and an aggressive paywall threaten its adoption, so the PM must prioritize notification reliability before expanding monetization gates.
Unlock 2 critical frictions, 1 market threat, 1 more prioritized move and the analyst’s take.
Access the full report for freeSources
- [1] App Store, source
Report last updated